Fengwu Chen

923 total citations · 2 hit papers
25 papers, 639 citations indexed

About

Fengwu Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fengwu Chen has authored 25 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fengwu Chen's work include Gut microbiota and health (6 papers), Blood properties and coagulation (4 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Fengwu Chen is often cited by papers focused on Gut microbiota and health (6 papers), Blood properties and coagulation (4 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Fengwu Chen collaborates with scholars based in China, United States and Pakistan. Fengwu Chen's co-authors include Kejun Hou, Dan Zhu, Zezhen Wu, Yi Wu, Junsong Zhou, Bangzhou Zhang, David W. Essex, Aizhen Yang, Zhenzhen Zhao and Junling Liu and has published in prestigious journals such as Circulation, Nature Communications and Blood.

In The Last Decade

Fengwu Chen

23 papers receiving 636 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study

2023 94 citations Zezhen Wu, Bangzhou Zhang et al. Frontiers in Cellular and Infection Microbiology profile →
The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019

2023 67 citations Junjun Ye, Yixi Wu et al. Frontiers in Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengwu Chen China	14	307	140	93	72	71	25	639
Xiaofang Hu China	15	340 1.1×	57 0.4×	43 0.5×	19 0.3×	78 1.1×	37	641
Aivars Lejnieks Latvia	13	139 0.5×	97 0.7×	117 1.3×	35 0.5×	52 0.7×	92	653
Yanjia Chen China	15	376 1.2×	82 0.6×	45 0.5×	19 0.3×	98 1.4×	37	811
Shiren Sun China	16	382 1.2×	127 0.9×	28 0.3×	11 0.2×	90 1.3×	41	836
Ndeye Coumba Ndiaye France	15	175 0.6×	146 1.0×	73 0.8×	28 0.4×	77 1.1×	35	555
Barbara Zapała Poland	14	373 1.2×	195 1.4×	67 0.7×	23 0.3×	68 1.0×	44	716
Haitao Chen China	21	418 1.4×	107 0.8×	87 0.9×	18 0.3×	64 0.9×	72	1.1k
Lingshu Wang China	13	277 0.9×	153 1.1×	89 1.0×	25 0.3×	71 1.0×	21	549
Bo Jiang China	17	307 1.0×	71 0.5×	52 0.6×	65 0.9×	179 2.5×	101	992
Manas Kumar Panigrahi India	17	245 0.8×	92 0.7×	75 0.8×	31 0.4×	26 0.4×	89	1.0k

Countries citing papers authored by Fengwu Chen

Since Specialization

Citations

This map shows the geographic impact of Fengwu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengwu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengwu Chen more than expected).

Fields of papers citing papers by Fengwu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengwu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengwu Chen. The network helps show where Fengwu Chen may publish in the future.

Co-authorship network of co-authors of Fengwu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Fengwu Chen. A scholar is included among the top collaborators of Fengwu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengwu Chen. Fengwu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Fengwu, Aizhen Yang, Yuxin Zhang, et al.. (2025). Differential transport pathways of saturated and unsaturated fatty acid esters in male mouse hepatocytes. Nature Communications. 16(1). 1344–1344.

Zhang, Shuo, Rui Zuo, Yufei Hu, et al.. (2024). Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes. Frontiers in Pharmacology. 15. 1370594–1370594. 1 indexed citations

Zhang, Yaqiong, et al.. (2024). Protein disulfide isomerase is essential for spermatogenesis in mice. JCI Insight. 9(12). 5 indexed citations

Ye, Junjun, et al.. (2023). The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019. Frontiers in Endocrinology. 14. 1192629–1192629. 67 indexed citations breakdown →

Su, Yu, Shuo Zhang, Zezhen Wu, et al.. (2023). Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes. Frontiers in Endocrinology. 14. 1054946–1054946. 4 indexed citations

Zhang, Shuo, Zezhen Wu, Dan Zhu, et al.. (2023). Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial. Frontiers in Pharmacology. 14. 1171399–1171399. 3 indexed citations

Wu, Zezhen, Bangzhou Zhang, Fengwu Chen, et al.. (2023). Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study. Frontiers in Cellular and Infection Microbiology. 12. 1089991–1089991. 94 indexed citations breakdown →

Chen, Fengwu, Jilin Li, Bangzhou Zhang, et al.. (2022). Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota. Frontiers in Molecular Biosciences. 9. 879294–879294. 19 indexed citations

Chen, Rongping, Dan Zhu, Rui Yang, et al.. (2022). Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease. Annals of Translational Medicine. 10(13). 750–750. 21 indexed citations

10.

Chen, Rongping, Bangzhou Zhang, Shuo Zhang, et al.. (2022). Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus. Frontiers in Immunology. 13. 930872–930872. 33 indexed citations

11.

Zhang, Shuo, Jingxian Chen, Fengwu Chen, et al.. (2022). Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review. Frontiers in Cellular and Infection Microbiology. 12. 1075201–1075201. 17 indexed citations

12.

Chen, Fengwu, Aizhen Yang, Xiaoying Wang, et al.. (2021). The disulfide bond Cys2724-Cys2774 in the C-terminal cystine knot domain of von Willebrand factor is critical for its dimerization and secretion. Thrombosis Journal. 19(1). 94–94.

13.

Cao, Man, Jianquan He, Qiang Zhang, et al.. (2021). Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential. Frontiers in Immunology. 12. 722206–722206. 65 indexed citations

14.

Li, Jilin, Rongping Chen, Dan Zhu, et al.. (2021). The effect of guar gum consumption on the lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition. 63(16). 2886–2895. 8 indexed citations

15.

Xu, Yanyan, Haojie Jiang, Li Li, et al.. (2020). Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets. Circulation. 142(1). 49–64. 83 indexed citations

16.

Wang, Bo, et al.. (2019). Plasma kallikrein contributes to ambient particulate matter-induced lung injury. Biochemical and Biophysical Research Communications. 518(3). 409–415. 6 indexed citations

17.

Zhao, Zhenzhen, Yi Wu, Junsong Zhou, et al.. (2018). The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses. Blood. 133(3). 246–251. 36 indexed citations

18.

Zhou, Junsong, Aizhen Yang, Fengwu Chen, et al.. (2018). Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation. Cell Communication and Signaling. 16(1). 98–98. 23 indexed citations

19.

Chen, Fengwu, et al.. (2018). Protein disulfide isomerase enhances tissue factor-dependent thrombin generation. Biochemical and Biophysical Research Communications. 501(1). 172–177. 21 indexed citations

20.

Yang, Aizhen, Fengwu Chen, Chao He, et al.. (2017). The Procoagulant Activity of Apoptotic Cells Is Mediated by Interaction with Factor XII. Frontiers in Immunology. 8. 1188–1188. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact